Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001828750-20-000003
Filing Date
2020-10-26
Accepted
2020-10-26 11:28:31
Documents
1
Effectiveness Date
2020-10-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10353
  Complete submission text file 0001828750-20-000003.txt   11391
Mailing Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301
Business Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301 805-491-1988
A2 Biotherapeutics, Inc. (Filer) CIK: 0001828750 (see all company filings)

EIN.: 822253911 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-378361 | Film No.: 201259583